SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, and The Leona M. and Harry B. Helmsley Charitable Trust will co-present at the fifth annual Partnering for Cures meeting taking place November 3-5, 2013 in New York City. Convened by FasterCures, the Washington, D.C.-based center of the Milken Institute, Partnering for Cures will bring together leaders across all medical research sectors with the express purpose of making collaboration happen.
Help employers find you! Check out all the jobs and post your resume.
